Consistent with this result, intense MDK immunoreactivity was detected in GBM tumors from N234 and N320 patients and in NCI131 xenograft tissues compared to adjacent normal brain tissues (Fig. 1f, Supplementary Fig. 2b). This evidence concerns the gene MDK and glioblastoma.